Houston's MD Anderson Cancer Center — consistently ranked the world's top cancer hospital — manages one of the largest CML and GIST patient populations globally. For Houston patients facing coverage gaps, high co-payments, or managing treatment between insurance approvals, Imatib 400mg delivers the same life-transforming Imatinib as brand Gleevec at dramatically reduced cost. MD Anderson's pioneering CML research established Imatinib as medicine's first molecularly targeted cancer therapy, and affordable access to this medicine remains a global priority.
Visit unnatipharmax.com | 📱 +91 82650 41513 | 📧 Unnatipharmax@gmail.com
